Trial Profile
A Phase 1/2 Study of Ad.p53 DC Vaccine in Combination With 1-methyl-D-tryptophan in Metastatic Solid Tumors and Invasive Breast Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Indoximod (Primary) ; INGN 225
- Indications Advanced breast cancer; Male breast cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 14 Mar 2018 Status changed from active, no longer recruiting to completed.
- 28 Sep 2017 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.
- 18 Apr 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.